Question 1

What is the catalog number for RPMI 1640 Medium Deficient w/o L-Glutamine, Methionine, Cystine (Liquid)?

Accepted Answer

The catalog number for RPMI 1640 Medium Deficient w/o L-Glutamine, Methionine, Cystine (Liquid) is R9016-L.

Question 2

What sizes are available for RPMI 1640 Medium Deficient w/o L-Glutamine, Methionine, Cystine (Liquid)?

Accepted Answer

RPMI 1640 Medium Deficient w/o L-Glutamine, Methionine, Cystine (Liquid) is available in the following size(s): 500 mL.

Question 3

Is RPMI 1640 Medium Deficient w/o L-Glutamine, Methionine, Cystine (Liquid) in stock?

Accepted Answer

RPMI 1640 Medium Deficient w/o L-Glutamine, Methionine, Cystine (Liquid) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Can this product be used for co-immunoprecipitation (Co-IP)?

Accepted Answer

Suitability for Co-IP depends on the specific antibody and is noted under validated applications on the datasheet. If it isn’t listed, contact our technical support team for guidance based on your target and sample type.

Question 5

Is this kit compatible with automated liquid handling platforms?

Accepted Answer

Automation compatibility varies by kit and isn’t always listed on the datasheet. Contact our technical support team with details of your platform so we can confirm with the manufacturer.

Question 6

What applications has this product been validated for?

Accepted Answer

Validated applications such as WB, ELISA, IHC, ICC, or FC are listed on the product datasheet. If you need application-specific validation data before ordering, contact our technical support team with the catalogue number.

RPMI 1640 Medium Deficient w/o L-Glutamine, Methionine, Cystine (Liquid)

Product Specifications

Frequently Asked Questions

Explore Other Products

Factor XIIIa (Coagulation Factor XIIIA Chain) (F13A1/3772R), CF568 conjugate, 0.1mg/mL

MCM7 (Proliferation Marker) (MCM7/2756R), CF405S conjugate, 0.1mg/mL

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2745), CF740 conjugate, 0.1mg/mL

Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (rGPC3/863), CF488A conjugate, 0.1mg/mL

CD14 (Monocyte / Macrophage Marker) (LPSR/2397), CF594 conjugate, 0.1mg/mL

Cyclin B2 (X29.2), CF647 conjugate, 0.1mg/mL